A recurring manufacturing quality issue at its Acton, MA facility has led to a second product correction, creating a significant financial liability.
Filing excerpt
While it is too early to ascertain the exact cost of this voluntary medical device correction, the Company expects to incur up to $50 million of costs associated with this correction in 2026, which will be excluded from adjusted results.
What this signalsFilings often name leadership changes, deals and spending plans.
Regions named
sec-8kmaterialContractGet every 8-K signal for Insulet and the companies you sell to, in the tools you already use.
Connect Autobound to Claude, Claude Code or Cursor with MCP. Then ask: “What changed at Insulet this week?”
The Signal API returns 8-K signals for any list of companies as JSON, for your CRM, warehouse or app.
Sign up and spend your free credits on the companies you sell to.
This page shows a preview. The full sec-8k record in the Signal API and MCP can also have these 8 fields. Some fields are empty for some signals.
Company
linkedin_urlValue in the APIindustriesValue in the APIemployee_count_lowValue in the APIemployee_count_highValue in the APIrevenueValue in the APIdescriptionValue in the APISignal
signal_nameValue in the APIassociationValue in the APIGET /v1/signals/090a5c36-0d73-4f1a-b61e-564589b0d464 returns this record as JSON. POST /v1/companies/enrich returns every signal for insulet.com.
{
"signal_id": "090a5c36-0d73-4f1a-b61e-564589b0d464",
"signal_type": "sec-8k",
"signal_subtype": "materialContract",
"detected_at": "2026-06-02T08:18:23.35+00:00",
"company": {
"name": "Insulet",
"domain": "insulet.com"
},
"data": {
"detail": "A recurring manufacturing quality issue at its Acton, MA facility has led to a second product correction, creating a significant financial liability. The company is implementing 'corrective actions' and 'enhanced quality controls', signaling an urgent need for solutions in quality management, process automation, and manufacturing oversight.",
"metrics": {
"timeframe": "current_quarter",
"dollar_context": "Expected costs associated with voluntary medical device correction",
"dollar_millions": 50
},
"summary": "Insulet to incur up to $50M in costs from medical device correction due to manufacturing issue.",
"excerpts": "While it is too early to ascertain the exact cost of this voluntary medical device correction, the Company expects to incur up to $50 million of costs associated with this correction in 2026, which will be excluded from adjusted results.",
"relevance": 0.9,
"sentiment": "negative",
"confidence": "medium",
"source_url": "https://www.sec.gov/Archives/edgar/data/1145197/000114519726000132/podd-20260526.htm",
"filing_date": "2026-05-26",
"filing_year": 2026,
"fiscal_year_end": "05/26",
"sales_relevance": "Vendor relationship signal",
"signal_category": "strategic",
"regions_mentioned": [
"Massachusetts"
]
}
}
curl https://signals.autobound.ai/v1/signals/090a5c36-0d73-4f1a-b61e-564589b0d464 \
-H "X-API-KEY: $AUTOBOUND_API_KEY"curl -X POST https://signals.autobound.ai/v1/companies/enrich \
-H "X-API-KEY: $AUTOBOUND_API_KEY" \
-H "Content-Type: application/json" \
-d '{"domain":"insulet.com","limit":20}'Long text fields are shortened on this page.
Looking up one signal by its id is free. Enrich costs 2 credits per signal returned; a call with no results is free.